About company

Quality Control for Molecular Diagnostics (QCMD) evolved from the successful European Union Concerted Action programmes which were initiated in the early 1990s to address quality control within the clinical diagnosis of viral Meningitis and Encephalitis. The QC programmes were expanded in 1998 through the establishment of a European Union funded project Quality Control Concerted Action (EU-QCCA). This enabled the issues of quality and standardisation to be reviewed in the wider context of diagnostic clinical virology and microbiology through the provision of QC material, proficiency testing (PT) or external quality assesment (EQA), and concensus best practice approaches.

GB
Unknown
Unknown
Not verified company